# Relates to the availability of opioid reversal agents

**Bill ID:** A8075DA
**Session:** 2024
**Sponsor:** Phil Steck
**Status:** In Senate Committee
**PDF:** [A8075DA PDF](https://legislation.nysenate.gov/pdf/bills/2024/A8075DA)

## Summary

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  8075--A
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  September 27, 2023
  ___________
 
 Introduced  by M. of A. STECK -- read once and referred to the Committee
  on Alcoholism and Drug Abuse -- committee  discharged,  bill  amended,
  ordered reprinted as amended and recommitted to said committee
 
 AN  ACT  to  amend  the mental hygiene law and the public health law, in
  relation to the availability of opioid antagonists

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Subdivision (l) of section 19.09 of the mental hygiene law,
 as  added  by  chapter  434  of  the laws of 2021, is amended to read as
 follows:
  (l)(1) The office, in consultation  with  the  department  of  health,
 shall  maintain  on  its  website  a publicly available directory of all
 distributors of opioid antagonists to  the  public,  including  but  not
 limited to, pharmacies, prevention programs and not-for-profits. As used
 in  this subdivision, the following terms shall have the following mean-
 ings:
  (i) "Opioid" means  an  opiate  as  defined  in  section  thirty-three
 hundred two of the public health law.
  (ii)  "Opioid  antagonist"  means  a federal food and drug administra-
 tion-approved drug that, when administered, negates  or  neutralizes  in
 whole  or  in part the pharmacological effects of an opioid in the body.
 The [opioid antagonist shall be limited to naloxone or other medications
 approved by the department of health for  this  purpose]  DEPARTMENT  OF
 HEALTH  SHALL MAKE AVAILABLE ANY FORMULATION AND DOSAGE OF OPIOID ANTAG-
 ONIST THAT ARE APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION.
  (2) The directory required by this subdivision shall  include  and  be
 searchable by the following information:
  (i) addresses of each distributor of opioid antagonists;
  (ii)  contact  information,  such as phone numbers or email addresses,
 for each distributor;
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD11983-02-3
 A. 8075--A  2
 
  (iii) services offered by each distributor at each  location  if  more
 than  one, as well as information providing which opioid antagonists are
 currently available at each distributor;
  (iv) special populations served;
  (v) insurance providers accepted;
  (vi) hours of operation of each distributor;
  (vii) contact information of opioid addiction prevention programs; and
  (viii) any other information the commissioner deems necessary.
  (3)  The  office  may  utilize  an  existing  directory to satisfy the
 requirements of this subdivision.
  (4) THE OFFICE SHALL ALLOW FOR CHOICE OF ANY FORMULATION AND DOSAGE OF
 OPIOID ANTAGONIST THAT ARE APPROVED BY THE FEDERAL FOOD AND DRUG  ADMIN-
 ISTRATION IN THE PURCHASE, DISTRIBUTION OR AUTHORIZATION TO PRESCRIBE OR
 DISPENSE SUCH PRODUCTS.
  ยง  2.  Subdivision  (b)  of section 25.18 of the mental hygiene law is
 amended by adding a new paragraph 4 to read as follows:
  4. ANY EXPENDITURE USED FOR THE PURCHASE OR DISTRIBUTION OF AN  OPIOID
 ANTAGONIST, AS DEFINED IN SUBPARAGRAPH (II) OF PARAGRAPH ONE OF SUBDIVI-
 SION  (L)  OF SECTION 19.09 OF THIS TITLE, SHALL ALLOW FOR CHOICE OF ANY
 FORMULATION OR DOSAGE THAT IS APPROVED BY  THE  FEDERAL  FOOD  AND  DRUG
 ADMINISTRATION.
  ยง  3.  Subparagraph  (i)  of paragraph (a) of subdivision 3 of section
 3309 of the public health law, as amended by chapter 42 of the  laws  of
 2014, is amended to read as follows:
  (i)  "Opioid  antagonist"  means  a drug approved by the Food and Drug
 Administration that, when administered, negates or neutralizes in  whole
 or in part the pharmacological effects of an opioid in the body. "Opioid
 antagonist"  shall be limited to naloxone and other medications approved
 by the department for such purpose, PROVIDED, HOWEVER, THAT THE  DEPART-
 MENT  SHALL  MAKE  AVAILABLE ANY FORMULATION AND DOSAGE OF OPIOID ANTAG-
 ONIST THAT ARE APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION.
  ยง 4. Section 3309 of the public health law is amended by adding a  new
 subdivision 9 to read as follows:
  9.  ANY  PURCHASE, DISTRIBUTION OR AUTHORIZATION TO PRESCRIBE PURSUANT
 TO THIS SECTION BY THE COMMISSIONER SHALL ALLOW FOR CHOICE OF ANY FORMU-
 LATION OR DOSAGE THAT IS APPROVED BY THE FEDERAL FOOD AND DRUG  ADMINIS-
 TRATION.
  ยง 5. This act shall take effect immediately.